NVRO 241220 17.50C (NVRO241220C17500) Stock Options, News & Quotes

US OptionsDetailed Quotes

NVRO241220C17500

Watchlist

1.50
0.000.00%

15min DelayTrading Apr 2 15:21 ET

0.00High0.00Low

Intraday

5D
Daily

News

Nevro's SI Joint Fixation System Delivers Enhanced Stability and Fusion for Patients
MassDevice11:21 ET
NVRO Stock Declines Despite Positive Study Data of Nevro1 System
Zacks Nov 19 08:35 ET
New Study Demonstrates Multiple Advantages of Nevro1, the Novel SI Joint Fusion System by Nevro, in Comparison to Posterolateral and Lateral Approaches
PR NewswireNov 18 08:30 ET
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
PR NewswireNov 15 08:30 ET
Nevro Stock May Gain on the CE Mark Certification for HFX IQ
Zacks Nov 15 07:35 ET
Express News | Engaged Capital LLC Cuts Share Stake in Nevro Corp to 1.5% as of Nov 12 - SEC Filing
ReutersNov 14 17:35 ET

Comments

Trytosaveabit

Nov 12 06:07

Update

$Nevro (NVRO.US)$ Reuters
6 mins ago
Nevro's Hfx Iq™ Spinal Cord Stimulation With AI Technology Receives Ce Mark Certification in Europe, Increasing Product Expansion Globally

Stock_Drift

Nov 11 16:19

After Hours Ticks. 5:18pm

$Impact BioMedical (IBO.US)$ $Adicet Bio (ACET.US)$ $Zoomcar Holdings (ZCAR.US)$ $Ryde Group (RYDE.US)$ $Foresight Autonomous (FRSX.US)$ $Check-Cap (CHEK.US)$ $Nvni Group (NVNI.US)$ $Bridger Aerospace (BAER.US)$ $Taoping (TAOP.US)$ $Scienjoy (SJ.US)$ $Nevro (NVRO.US)$ $Taysha Gene Therapies (TSHA.US)$ $MultiMetaVerse (MMV.US)$ $XBP Europe Holdings (XBP.US)$

Jaguar8

Sep 24 07:02

NEWS

$Nevro (NVRO.US)$
Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation
Nevro Corp. (NYSE: NVRO) has announced the FDA approval and market release of HFX iQ™ with HFX AdaptivAI™, an AI-driven spinal cord stimulation (SCS) system for chronic pain management. This technology leverages insights from over 100,000 patients and more than 100 million data points to provide personalized, responsive pain relief in real time.
Key features of HFX Adaptiv...

Newbee4

Aug 8 06:22

Do you have any thoughts on this?

$Nevro (NVRO.US)$ @Trytosaveabit

Moomoo AI

Feb 25 07:35

Nevro's low P/S ratio may be due to its poor revenue outlook. Shareholders accept this as they anticipate no future revenue surprises. These conditions could continue to limit the share price.

Benign Growth For Nevro Corp. (NYSE:NVRO) Underpins Its Share Price